Prevent preclinical drug development program: cgmp production of vaccines and biologicals for cancer prevention
Ended Awarded Last action
- Contract number
- 75N91019D00027
- Awardee
-
Kindred Biosciences, Inc. UEI GQEBHPTLG7Y1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $576,174 obligated
Award facts
- Opportunity
-
- N01CN8700618 Solicitation number
- Combined order value
-
- $576,174 Current, with exercised options
- $1,321,344 Potential, with all options
- Last date to order 100% complete
- IDV ceiling 1% used
- $49,995,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Cgmp RE-supply of HPV 16L1/16RG1 | National Cancer Institute (NIH) | $576,173 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N91019D00027?
75N91019D00027 was awarded to Kindred Biosciences, Inc. by National Cancer Institute (National Institutes of Health) on August 14, 2019.
How much is contract 75N91019D00027 worth?
Orders under 75N91019D00027 have obligated $576,174. Their combined potential value, with all options, is $1,321,344. 75N91019D00027's own ceiling is $49,995,000.
How many orders have been placed under contract 75N91019D00027?
1 order has been placed under 75N91019D00027, the latest on February 26, 2021.
Who can order from contract 75N91019D00027?
75N91019D00027 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N91019D00027 part of a contract vehicle?
Yes. 75N91019D00027 is part of PREVENT Cancer Preclinical Drug Development Program.
Was contract 75N91019D00027 competed?
The extent of competition for 75N91019D00027 was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV